Article Text

Download PDFPDF
Clinical features and risk factors of postsurgical gout
  1. E H Kang,
  2. E Y Lee,
  3. Y J Lee,
  4. Y W Song,
  5. E B Lee
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Medical Research Center, Seoul National University, Seoul, Korea
  1. E B Lee, Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Jongno-gu, Seoul, Korea 110–740; leb7616{at}


Objectives: To investigate the clinical characteristics and risk factors of gout attacks that develop during the postsurgical period.

Methods: We enrolled 67 patients with gout who developed postsurgical gout and 67 controls who had histories of gout but did not develop gout attacks after surgery. Features of the postsurgical gout attacks were analysed and compared to those of presurgical gout attacks suffered by patients and controls. Demographics, medical backgrounds, laboratory data and surgical factors were compared between patients and controls in order to establish risk factors associated with postsurgical gout.

Results: The mean (SD) time interval to develop postsurgical gout was 4.2 (3.1) days. The attacks tended to involve lower extremity joints (65/67, 97.0%), usually the first metatarsophalangeal joint (42/67, 62.7%), and to affect more than one joint (34/67, 50.7%). The number of attacked joints was positively correlated with the total number of previously involved joints (r = 0.281, p = 0.026). The site of attacks had a preference for the previously affected sites. A history of cancer surgery (p = 0.002), elevated presurgical serum urate levels (⩾9 mg/dl; p = 0.002) and failure to administer colchicine prophylaxis (p = 0.008) were found to be risk factors for postsurgical gout.

Conclusions: Postsurgical gout tends to develop within 8 days after surgery. The site and number of involved joints reflect the features of gout attacks the patient suffered before surgery. Adequate presurgical control of serum uric acid levels and/or prophylactic administration of colchicine will help prevent gout attacks during the postsurgical period.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • ▸ Supplementary tables 1 and 2 are published online only at

  • Funding: This study was supported by a grant of the Korea Health 21 R&D Project from the Ministry of Health & Welfare, Republic of Korea (03-PJ10-PG13-GD01-0002).

  • Competing interests: None declared.